Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

First look inside Sygnature Discovery’s new £30 million HQ – the “Discovery Building”

Dr Jonathan Williams, COO, has given the “Nottingham Post” a tour of the “Discovery Building”, Sygnature’s new “landmark” facility located in BioCity Nottingham.  The company will begin the move into the new, state-of-the-art building later this month.

Dr Williams told the “Nottingham Post”:

“After Oxford, Cambridge and London, Nottingham is probably the most vibrant area for bioscience research in the country.  Internationally, it’s difficult to know where it stands but Sygnature and other companies at BioCity have contracts worldwide.”

“For the past 12 years-plus, Sygnature Discovery has been doing really well but has got on with its business quite quietly.  This will really raise the profile of the company and of Nottingham in terms of what’s going on here.”

To read the “Nottingham Post” article in full, go to: http://www.nottinghampost.com/first-look-inside-biocity-s-new-30m-biosciences-hub-that-illuminates-at-night/story-30261085-detail/story.html

Latest News

View All

Sygnature Discovery and Daewoong Pharma announce research…

New platform set to accelerate early-stage targeted…

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…